C. Tang, B. T. Ang, and S. Pervaiz, Cancer stem cell: target for anti-cancer therapy, The FASEB Journal, vol.21, issue.14, pp.3777-3785, 2007.
DOI : 10.1096/fj.07-8560rev

I. Sanchez-garcia, C. Vicente-duenas, and C. Cobaleda, The theoretical basis of cancer-stem-cell-based therapeutics of cancer: can it be put into practice?, BioEssays, vol.212, issue.12, pp.1269-1280, 2007.
DOI : 10.1002/bies.20679

A. Smith, A glossary for stem-cell biology, Nature, vol.441, issue.7097, p.1060, 2006.
DOI : 10.1038/nature04954

P. B. Cusimano and . Dirks, Identification of human brain tumour initiating cells, Nature, vol.432, pp.396-401, 2004.

L. Ricci-vitiani, D. G. Lombardi, E. Pilozzi, M. Biffoni, M. Todaro et al., Identification and expansion of human colon-cancer-initiating cells, Nature, vol.37, issue.7123, pp.111-116, 2007.
DOI : 10.1038/nature05384

C. A. O-'brien, A. Pollett, S. Gallinger, and J. E. Dick, A human colon cancer cell capable of initiating tumour growth in immunodeficient mice, Nature, vol.445, pp.106-116, 2007.

D. M. Huang, A. A. Simeone, G. Shelton, C. Parmiani, M. F. Castelli et al., Phenotypic characterization of human colorectal cancer stem cells, Proc Natl Acad Sci U S A, vol.104, pp.10158-63, 2007.

M. Al-hajj, M. S. Wicha, A. Benito-hernandez, S. J. Morrison, and M. F. Clarke, Prospective identification of tumorigenic breast cancer cells, Proceedings of the National Academy of Sciences, vol.100, issue.7, pp.3983-3991, 2003.
DOI : 10.1073/pnas.0530291100

S. Zhang, C. Balch, M. W. Chan, H. C. Lai, D. Matei et al., Identification and Characterization of Ovarian Cancer-Initiating Cells from Primary Human Tumors, Cancer Research, vol.68, issue.11, pp.4311-4331, 2008.
DOI : 10.1158/0008-5472.CAN-08-0364

C. Wu and B. A. Alman, Side population cells in human cancers, Cancer Letters, vol.268, issue.1, pp.1-9, 2008.
DOI : 10.1016/j.canlet.2008.03.048

T. Kondo, T. Setoguchi, and T. Taga, Persistence of a small subpopulation of cancer stem-like cells in the C6 glioma cell line, Proceedings of the National Academy of Sciences, vol.101, issue.3, pp.781-786, 2004.
DOI : 10.1073/pnas.0307618100

M. K. Goodell and . Brenner, side population" of cells with high drug efflux capacity in human tumor cells, Proc. Natl. Acad. Sci. U S A, vol.101, pp.14228-14233, 2004.

R. P. Hill, Identifying Cancer Stem Cells in Solid Tumors: Case Not Proven, Cancer Research, vol.66, issue.4, pp.1891-510, 2006.
DOI : 10.1158/0008-5472.CAN-05-3450

D. Wion and F. Berger, Cancer stem cells, N. Engl. J. Med, pp.355-2703, 2006.
URL : https://hal.archives-ouvertes.fr/inserm-00390762

P. N. Kelly, A. Dakic, J. M. Adams, S. L. Nutt, and A. Strasser, Tumor Growth Need Not Be Driven by Rare Cancer Stem Cells, Science, vol.317, issue.5836, 2007.
DOI : 10.1126/science.1142596

L. L. Campbell and K. Polyak, Breast Tumor Heterogeneity: Cancer Stem Cells or Clonal Evolution?, Cell Cycle, vol.6, issue.19, pp.2332-2338, 2007.
DOI : 10.4161/cc.6.19.4914

J. Rak, Is cancer stem cell a cell, or a multicellular unit capable of inducing angiogenesis?, Medical Hypotheses, vol.66, issue.3, pp.601-604, 2006.
DOI : 10.1016/j.mehy.2005.09.004

D. Adamski, J. F. Mayol, N. Platet, F. Berger, F. Herodin et al., Effects of Hoechst 33342 on C2C12 and PC12 cell differentiation, FEBS Letters, vol.4, issue.16, pp.581-3076, 2007.
DOI : 10.1016/j.febslet.2007.05.073

URL : https://hal.archives-ouvertes.fr/inserm-00382266

N. Platet, J. F. Mayol, F. Berger, F. Herodin, and D. Wion, Fluctuation of the SP/non-SP phenotype in the C6 glioma cell line, FEBS Letters, vol.294, issue.7, pp.581-1435, 2007.
DOI : 10.1016/j.febslet.2007.02.071

URL : https://hal.archives-ouvertes.fr/inserm-00383790

X. Zheng, G. Shen, X. Yang, and W. Liu, Most C6 Cells Are Cancer Stem Cells: Evidence from Clonal and Population Analyses, Cancer Research, vol.67, issue.8, pp.3691-3697, 2007.
DOI : 10.1158/0008-5472.CAN-06-3912

Y. Zhong, C. Zhou, W. Ma, D. Wang, S. Guo et al., Most MCF7 and SK-OV3 cells were deprived of their stem nature by Hoechst 33342, Biochemical and Biophysical Research Communications, vol.364, issue.2, pp.364-338, 2007.
DOI : 10.1016/j.bbrc.2007.10.016

F. Ruckauer and . Beuschlein, Side population does not define stem cell-like cancer cells in the adrenocortical carcinoma cell line NCI h295R, Endocrinology, vol.196, pp.1314-1322, 2007.

G. M. Assanah, M. B. Mckhann, P. C. Sisti, P. Mccormick, J. N. Canoll et al., Identification of A2B5+CD133-tumor-initiating cells in adult human gliomas, Neurosurgery, vol.62, pp.505-514, 2008.

G. D. Thurston, M. D. Yancopoulos, N. Angelica, D. Kemeny, S. Lyden et al., CD133 expression is not restricted to stem cells, and both CD133+ and CD133-metastatic colon cancer cells initiate tumors, J Clin Invest, vol.118, pp.2111-2131, 2008.

R. Koch, Uber bakteriologische Forschung Verhandlung des X Internationalen Medichinischen Congresses, Xth International Congress of Medicine, p.1890

D. N. Fredericks and D. A. Relman, Sequence-based identification of microbial pathogens: a reconsideration of Koch's postulates, Clin. Microbiol. Rev, vol.9, pp.18-33, 1996.

A. S. Evans, Causation and disease: the Henle-Koch postulates revisited, Yale J. Biol. Med, vol.49, pp.175-195, 1976.
DOI : 10.1007/978-1-4615-3024-4

H. D. Isenberg, Pathogenicity and virulence: another view., Clinical Microbiology Reviews, vol.1, issue.1, pp.40-53, 1988.
DOI : 10.1128/CMR.1.1.40

T. M. Rivers, Viruses and Koch's Postulates, J. Bacteriol, vol.33, pp.1-12, 1937.

Y. Valladares, Forms of the Cancerigenic Principle, Cell Clones, and Koch???s Postulates, Pharmacology, vol.16, issue.5, pp.462-480, 1967.
DOI : 10.1159/000137029

S. Lee, Y. Kotliarova, A. Kotliarov, Q. Li, N. M. Su et al., Tumor stem cells derived from glioblastomas cultured in bFGF and EGF more closely mirror the phenotype and genotype of primary tumors than do serum-cultured cell lines, Cancer Cell, vol.9, issue.5, pp.391-403, 2006.
DOI : 10.1016/j.ccr.2006.03.030

N. Platet, S. Y. Liu, M. E. Atifi, L. Oliver, F. M. Vallette et al., Influence of oxygen tension on CD133 phenotype in human glioma cell cultures, Cancer Letters, vol.258, issue.2, pp.286-90, 2007.
DOI : 10.1016/j.canlet.2007.09.012

URL : https://hal.archives-ouvertes.fr/inserm-00382779

R. Axelrod, D. E. Axelrod, and K. J. Pienta, Evolution of cooperation among tumor cells, Proceedings of the National Academy of Sciences, vol.103, issue.36, pp.13474-13479, 2006.
DOI : 10.1073/pnas.0606053103

E. Laconi, The evolving concept of tumor microenvironments, BioEssays, vol.532, issue.8, pp.738-744, 2007.
DOI : 10.1002/bies.20606

L. Li and W. B. Neaves, Normal Stem Cells and Cancer Stem Cells: The Niche Matters, Cancer Research, vol.66, issue.9, pp.4553-4557, 2006.
DOI : 10.1158/0008-5472.CAN-05-3986

A. E. Karnoub, A. B. Dash, A. P. Vo, A. Sullivan, M. W. Brooks et al., Mesenchymal stem cells within tumour stroma promote breast cancer metastasis, Nature, vol.9, issue.7162, pp.557-563, 2007.
DOI : 10.1038/nature06188

M. P. Shekhar, R. Pauley, and G. Heppner, Host microenvironment in breast cancer development: Extracellular matrix???stromal cell contribution to neoplastic phenotype of epithelial cells in the breast, Breast Cancer Research, vol.87, issue.3, pp.130-135, 2003.
DOI : 10.1073/pnas.87.1.75

M. M. Mueller and N. E. Fusenig, Friends or foes ??? bipolar effects of the tumour stroma in cancer, Nature Reviews Cancer, vol.22, issue.11, pp.839-849, 2004.
DOI : 10.1038/nrc1477

K. M. Joo, S. Y. Kim, X. Jin, S. Y. Song, D. S. Kong et al., Clinical and biological implications of CD133-positive and CD133-negative cells in glioblastomas, Laboratory Investigation, vol.55, issue.8, pp.808-815, 2008.
DOI : 10.1186/1476-4598-5-67

M. E. Laughlin-drubin and K. Munger, Viruses associated with human cancer, Biochim. Biophys. Acta, vol.178, pp.127-150, 2008.

R. Pardal, M. F. Clarke, and S. J. Morrison, Applying the principles of stem-cell biology to cancer, Nature Reviews Cancer, vol.3, issue.12, pp.895-902, 2003.
DOI : 10.1038/nrc1232

I. J. Fidler, S. Yano, R. D. Zhang, T. Fujimaki, and C. D. Bucana, The seed and soil hypothesis: vascularisation and brain metastases, The Lancet Oncology, vol.3, issue.1, pp.53-57, 2002.
DOI : 10.1016/S1470-2045(01)00622-2

A. M. Soto and C. Sonnenschein, The somatic mutation theory of cancer: growing problems with the paradigm?, BioEssays, vol.111, issue.10, pp.1097-1107, 2004.
DOI : 10.1002/bies.20087

C. Sonnenschein and A. M. Soto, Theories of carcinogenesis: An emerging perspective, Seminars in Cancer Biology, vol.18, issue.5, pp.372-377, 2008.
DOI : 10.1016/j.semcancer.2008.03.012

A. Albini and M. B. Sporn, The tumour microenvironment as a target for chemoprevention, Nature Reviews Cancer, vol.10, issue.2, pp.139-186, 2007.
DOI : 10.1038/nrc2067

J. A. Joyce, Therapeutic targeting of the tumor microenvironment, Cancer Cell, vol.7, issue.6, pp.513-520, 2005.
DOI : 10.1016/j.ccr.2005.05.024

R. Kalluri and M. Zeisberg, Fibroblasts in cancer, Nature Reviews Cancer, vol.59, issue.5, pp.392-401, 2006.
DOI : 10.1038/nrc1877

P. A. Kenny and M. J. Bissell, Tumor reversion: Correction of malignant behavior by microenvironmental cues, International Journal of Cancer, vol.1, issue.5, pp.688-695, 2003.
DOI : 10.1002/ijc.11491

M. J. Hendrix, E. A. Seftor, R. E. Seftor, J. Kasemeier-kulesa, P. M. Kulesa et al., Reprogramming metastatic tumour cells with embryonic microenvironments, Nature Reviews Cancer, vol.64, issue.4, pp.246-255, 2007.
DOI : 10.1038/nrc2108

A. Sica, P. Allavena, and A. Mantovani, Cancer related inflammation: The macrophage connection, Cancer Letters, vol.267, issue.2, pp.204-215, 2008.
DOI : 10.1016/j.canlet.2008.03.028

L. Cegelski, G. R. Marshall, G. R. Eldridge, and S. J. Hultgren, The biology and future prospects of antivirulence therapies, Nature Reviews Microbiology, vol.92, issue.1, pp.17-27, 2008.
DOI : 10.1038/nrmicro1818

R. L. Nagel, Epistasis and the genetics of human diseases, Comptes Rendus Biologies, vol.328, issue.7, pp.606-615, 2005.
DOI : 10.1016/j.crvi.2005.05.003